Table 1 Patient characteristics
|  | FAS (n = 205) | FAS BKPyVAN or high (n = 35) | FAS non BKPyVAN or high (n = 170) | PP (n = 159) | PP BKPyVAN or high (n = 34) | PP non BKPyVAN or high (n = 125) | BKPyVAN (n = 10) |
|---|---|---|---|---|---|---|---|
BKPyVAN | 10 (4.9) | Â | Â | 10 (6.3) | Â | Â | Â |
Time to BKPyV (d) | 83.5 | 93 | Â | 83.5 | 92.5 | Â | 83.5 |
Male sex | 134 (65.4) | 29 (82.3) | 105 (61.8) | 106 (66.7) | 28 (82.4) | 78 (62.4) | 10 (100.0) |
Age | 54.8 | 60.3 | 53.7 | 56.1 | 59.8 | 55.1 | 57.4 |
Weight | 78.2 | 82.1 | 77.4 | 77.7 | 82.4 | 76.5 | 84.5 |
Height | 173.1 | 174.8 | 172.8 | 173.0 | 175.0 | 172.5 | 177.8 |
BMI | 26.1 | 26.8 | 26.0 | 26.0 | 26.8 | 25.8 | 26.8 |
Diabetes | 44 (21.5) | 9 (24.3) | 35 (20.8) | 39 (24.5) | 9 (25.0) | 30 (24.4) | 3 (30.0) |
Primary cause of renal failure | Â | Â | Â | Â | Â | Â | Â |
Glomerulonephritis | 49 (23.9) | 7 (18.9) | 42 (25.0) | 35 (22.0) | 7 (19.4) | 28 (22.8) | 3 (30.0) |
Diabetes | 37 (18.0) | 8 (21.6) | 29 (17.3) | 33 (20.6) | 8 (22.2) | 25 (20.3) | 3 (30.0) |
Cystic/Hereditary/ Congenital | 24 (11.7) | 4 (10.8) | 20 (11.9) | 17 (10.7) | 4 (11.1) | 13 (10.6) | 1 (10.0) |
Hypertension/Large vessel disease | 31 (15.1) | 7 (20.0) | 24 (14.1) | 25 (15.7) | 7 (20.6) | 18 (14.4) | 1 (10.0) |
Miscellaneous/unknown | 57 (27.8) | 8 (22.6) | 49 (28.8) | 44 (27.7) | 7 (20.6) | 37 (29.6) | 2 (20.0) |
Interstitial nephritis/pyelonephritis | 6 (2.9) | 1 (2.7) | 5 (3.0) | 4 (2.5) | 1 (2.8) | 3 (2.4) | 0 (0) |
Vasculitis/Secondary glomerulonephritis | 1 (0.5) | 0 (0) | 1 (0.6) | 1 (0.6) | 0 (0) | 1 (0.8) | 0 (0) |
Simultaneous pancreas tx | 2 (1.0) | 1 (2.7) | 1 (0.6) | 2 (1.3) | 1 (2.8) | 1 (0.8) | 1 (10.0) |
ABO incompatible | 21 (10.2) | 4 (10.8) | 17 (10.1) | 16 (10.1) | 4 (11.1) | 12 (9.8) | 0 (0) |
First tx | 187 (91.2) | 32 (91.4) | 155 (91.2) | 147 (92.5) | 31 (91.2) | 116 (92.8) | 10 (100.0) |
Second tx | 16 (7.8) | 3 (8.1) | 13 (7.7) | 11 (6.9) | 3 (8.3) | 8 (6.5) | 0 (0) |
Third or more tx | 2 (1.0) | 0 (0) | 2 (1.2) | 1 (0.6) | 0 (0) | 1 (0.8) | 0 (0) |
Living donor | 73 (35.6) | 10 (27.0) | 63 (37.5) | 51 (32.1) | 10 (27.8) | 41 (33.3) | 1 (10.0) |
Donor age | 54.4 | 61.1 | 53.0 | 56.4 | 60.8 | 55.2 | 59.4 |
Donor male sex | 99 (48.3) | 15 (42.3) | 84 (49.4) | 78 (49.1) | 15 (44.1) | 63 (50.4) | 4 (40.0) |
Recipient CMV+ | 138 (67.3) | 24 (68.6) | 114 (67.1) | 107 (67.3) | 23 (67.6) | 84 (67.2) | 5 (50.0) |
Donor CMV+ | 149 (72.7) | 30 (85.7) | 119 (70.0) | 115 (72.3) | 29 (85.3) | 86 (68.8) | 8 (80.0) |
CMV mismatch (d+/r-) | 44 (21.5) | 10 (27.0) | 34 (20.2) | 36 (22.6) | 10 (27.8) | 26 (21.1) | 4 (40.0) |
Delayed graft function (d) | 1.9 | 2.1 | 1.9 | 2.0 | 2.1 | 2.0 | 1.9 |
Enhanced induction | 31 (15.1) | 5 (13.5) | 26 (15.5) | 23 (14.5) | 5 (13.9) | 18 (14.6) | 1 (10.0) |
Rejection treatment | 48 (23.4) | 10 (27.0) | 38 (22.6) | 40 (25.2) | 9 (25.0) | 31 (25.2) | 5 (50.0) |
SM-resistant rejection treatment | 13 (6.3) | 1 (2.7) | 12 (7.1) | 11 (6.9) | 1 (2.8) | 10 (8.1) | 1 (10.0) |
Graft loss or death | 10 (4.9) | 1 (2.7) | 9 (5.4) | 10 (6.3) | 1 (2.8) | 9 (7.3) | 1 (10.0) |
Death | 3 (1.5) | 0 (0) | 3 (1.8) | 3 (1.9) | 0 (0) | 3 (2.4) | 0 (0) |